Abstract
Cannabis is one of the most commonly used illicit drugs. It is a psychoactive drug with tetrahydrocannabinol being the main active ingredient. With increasing decriminalization and legalization of marijuana use in the USA, it is essential to study its long-Term effects on cardiovascular diseases, a leading cause of death in the USA. Cannabis can trigger acute myocardial infarction in otherwise healthy young individuals, affect atherogenesis, arrhythmia, develop Takotsubo cardiomyopathy and cannabis arteritis. The only definitive treatment for these pathologies is complete abstinence. In this review we focus on discussing the long-Term effects of tetrahydrocannabinol on cardiovascular pathologies, its pathophysiology and a brief discussion on its clinical features and definitive management.
Original language | English (US) |
---|---|
Pages (from-to) | 883-890 |
Number of pages | 8 |
Journal | Future Cardiology |
Volume | 18 |
Issue number | 11 |
DOIs | |
State | Published - 2022 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Cardiology and Cardiovascular Medicine